|
Volume 271, Number 47,
Issue of November 22, 1996
pp. 29830-29838
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Human Monocyte Interleukin-1 Posttranslational Processing
EVIDENCE OF A VOLUME-REGULATED RESPONSE*
(Received for publication, June 28, 1996, and in revised form, August 29, 1996)
David G.
Perregaux
,
Ronald E.
Laliberte
and
Christopher A.
Gabel
From the Department of Cancer, Immunology, and Infectious Diseases,
Central Research, Pfizer Inc., Groton, Connecticut 06340
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
Interleukin (IL)-1 produced by monocytes and
macrophages is not released via the normal secretory apparatus, and
prior to its release, this cytokine must be proteolytically processed
to generate a mature biologically active species. Biochemical
mechanisms that regulate these posttranslational steps are not well
understood. Lipopolysaccharide (LPS) is a poor activator of IL-1
posttranslational processing despite serving as a potent inducer of
IL-1 synthesis. For example, freshly isolated human monocytes treated
with LPS released <30% of their newly synthesized IL-1 as the
mature 17-kDa cytokine species, and monocytes that were aged overnight
in culture prior to LPS treatment released no 17-kDa cytokine. In
contrast, addition of extracellular ATP promoted IL-1
posttranslational processing from both monocyte populations. Previous
studies indicated that ATP, acting via surface P2Z-type
receptors, promoted major intracellular ionic changes. To explore
whether these ionic changes were required for cytokine
posttranslational processing, LPS-stimulated human monocytes were
maintained in ionically altered media. Hypotonic conditions promoted an
efficient and selective release of mature 17-kDa IL-1 from
LPS-activated monocytes in the absence of ATP. In contrast, hypertonic
conditions blocked the ATP-induced posttranslational processing
reactions. Both hypotonic stress- and ATP-induced processing were
blocked when NaI was substituted for NaCl within the medium; substitution with NaSCN or NaNO3 also blocked the ATP
response, but these salts were less inhibitory against the hypotonic
stimulus. Sodium glucuronate substitution did not inhibit cytokine
processing induced by either stimulus. Removal of divalent cations from
the medium did not affect the ATP response, but pretreatment of
monocytes with the phosphatase inhibitor okadaic acid
dose-dependently suppressed ATP-induced IL-1
posttranslational processing. A volume-induced change to the
intracellular ionic environment, therefore, may represent a key element
of the mechanism by which IL-1 posttranslational processing is
initiated. The strong dependence of this cytokine release mechanism on
chloride anions suggests that selective anion transporters function as
important components of this response.
INTRODUCTION
Interleukin (IL)1-1 is produced by
many cells in response to inflammatory stimuli such as
lipopolysaccharide (LPS) and tumor necrosis factor (1, 2). When
administered to target cells, IL-1 binds to cell-surface receptors
and promotes various pro-inflammatory activities including enhanced
production of matrix metalloproteinases, increased expression of
adhesion molecules, and enhanced prostaglandin synthesis (3, 4, 5, 6). In
view of its many pro-inflammatory activities, in vivo
production of IL-1 is likely to be controlled at many levels.
Indeed, recent in vitro studies indicate that IL-1
production is regulated via both transcriptional and posttranslational mechanisms (7, 8, 9, 10, 11, 12, 13, 14, 15, 16). Mouse peritoneal macrophages, for example,
synthesize large quantities of IL-1 mRNA and protein in response
to LPS stimulation. This translated product, however, corresponds to
the inactive 35-kDa pro-IL-1 species which is neither
proteolytically processed nor released into the medium (13, 14).
Externalization and proteolytic maturation of the pro-IL-1
polypeptide requires an additional stimulus. To date, identified agents
that can serve as this secondary stimulus in vitro include
ATP, cytolytic T-cells, and potassium ionophores such as nigericin (13,
14, 16). Likewise, production of mature biologically active IL-1 by
LPS-stimulated freshly isolated human monocytes can be dissociated into
two distinct steps. Low concentrations of LPS activate monocytes to
produce pro-IL-1 , but this newly synthesized cytokine is not
proteolytically processed or released (15). On the other hand, high
concentrations of LPS (>20 ng/ml) promote synthesis of comparable
levels of pro-IL-1 and, in addition, stimulate its release and
maturation (15).
The efficiency of IL-1 release from human monocytes treated only with
LPS is variable and correlates with release of the cytoplasmic enzyme
lactate dehydrogenase (LDH) (17). Moreover, agents like ATP and
nigericin that promote efficient externalization of mature 17-kDa
IL-1 from LPS-treated murine peritoneal macrophages cause cell
death, possibly via an apoptotic mechanism (13). Interestingly, the
enzyme responsible for the proteolytic cleavage of pro-IL-1 to its
mature counterpart, interleukin convertase (ICE), is a homolog of the
Caenorhabditis elegans cell death gene ced-3
(18), and overexpression of murine ICE in rat fibroblasts leads to
apoptotic-like features (19). These observations suggest that the
posttranslational processing and release of pro-IL-1 may be linked
to cell death.
In a previous study we compared the processes by which nigericin and
ATP promoted the posttranslational maturation of IL-1 from
LPS-stimulated murine peritoneal macrophages (20). Both of these agents
promoted efflux of potassium from the cell, and this efflux appeared
necessary for the posttranslational processing reactions. This
requirement for K+ export was confirmed recently, and two
non-selective inhibitors of K+ channels, triethanolamine
and 4-aminopyridine, were reported to block cytokine maturation (21).
In a related study, release of mature IL-1 from LPS-stimulated human
monocytes and mouse peritoneal macrophages was shown to be impaired by
agents that disrupted anion transport processes, including DIDS,
ethacrynic acid, and tenidap, a new anti-inflammatory/anti-arthritic
agent (16). Changes to the intracellular ionic environment, therefore, appear to be required for activation of the posttranslational maturation of pro-IL-1 . In the present study we have continued to
explore ionic conditions required for this unusual cytokine processing
event. ATP and hypotonic stress are employed as alternative signals to
activate human monocyte IL-1 posttranslational processing. Sensitivity of these cellular activation processes to changes of the
ionic environment and to pharmacological effectors suggests that an
anion transporter is a necessary component of the mechanism by which
both hypotonic stress and ATP promote IL-1 posttranslational processing.
EXPERIMENTAL PROCEDURES
Human Monocytes
Mononuclear cells were isolated from blood
(100 ml) drawn from normal volunteers as described previously (16). In
an average experiment, 1 × 107 mononuclear cells were
added to each well of 6-well dishes in a total volume of 2 ml of RPMI
1640 containing 5% FBS, 25 mM Hepes, pH 7.2, and 1%
penicillin/streptomycin (Maintenance Medium). Monocytes were allowed to
adhere for 2 h, after which the supernatants were discarded and
the attached cells were rinsed once with 2 ml of Maintenance
Medium.
When freshly isolated monocytes were employed, the adherent cells
immediately were exposed to 10 ng/ml LPS (Escherichia coli serotype 055:B5, Sigma) for 2 h. Alternatively,
the adherent monocytes were incubated overnight at 37 °C in a 5%
CO2 environment in Maintenance Medium prior to LPS
activation; where indicated, 5 ng/ml recombinant human granulocyte
macrophage colony stimulating factor (R & D Systems, Minneapolis, MN)
was added to the culture medium. In all cases LPS-stimulated cells were
labeled for 60 min in 1 ml of Pulse Medium (methionine-free RPMI 1640, 1% dialyzed FBS, 25 mM Hepes, pH 7.2, 83 µCi/ml
[35S]methionine (Amersham Corp., 1000 Ci/mmol)). The
Pulse Medium subsequently was discarded; the radiolabeled cells were
washed once with 2 ml of Chase Medium (RPMI 1640, 1% FBS, 20 mM Hepes, 5 mM NaHCO3, pH 6.9), and
1 ml of Chase Medium that contained various effector molecules was
added to each well. Where indicated, ATP was added (from a 100 mM stock solution previously adjusted to pH 7 with NaOH) to
a final concentration of 1-5 mM. Radiolabeled monocytes
were chased at 37 °C for various times after which the medium was
recovered and clarified by centrifugation to remove cells that detached
from the plate during the chase and cell debris; the resulting
supernatants were harvested and adjusted to 1% in Triton X-100, 0.1 mM phenylmethylsulfonyl fluoride, 1 mM
iodoacetic acid, 1 µg/ml pepstatin, and 1 µg/ml leupeptin by
addition of concentrated stock solutions of these reagents. Cells were
solubilized by addition of 1 ml of an extraction buffer composed of 25 mM Hepes, pH 7, 1% Triton X-100, 150 mM NaCl,
0.1 mM phenylmethylsulfonyl fluoride, 1 mM
iodoacetic acid, 1 µg/ml pepstatin, 1 µg/ml leupeptin, and 1 mg/ml
ovalbumin. After a 30-min incubation on ice, both the media and cell
extracts were clarified by centrifugation at 45,000 rpm for 30 min in a
Beckman tabletop ultracentrifuge using a TLA 45 rotor (Beckman
Instruments, Palo Alto, CA).
Immunoprecipitation of IL-1 and Analysis of Radiolabeled
Cytokine Product
IL-1 was immunoprecipitated from detergent
extracts of cell and media samples as detailed previously (16).
Disaggregated immunoprecipitates were analyzed by SDS-gel
electrophoresis and autoradiography (22); gels were soaked in Amplify
(Amersham Corp.) prior to drying. Quantitation of the amount of
radioactivity associated with the various species of IL-1 was
determined with the use of an Ambis Image Analysis System (San Diego,
CA).
Lactate Dehydrogenase (LDH) Assays
Aliquots of media
samples and cell extracts were assayed for LDH using pyruvate as
substrate and a colorimetric pyruvate detection assay
(Sigma).
Isotonic Media
A modified Dulbecco's based formulation was
employed to prepare isotonic medium (20 mM Hepes, pH 7.2, 137 mM NaCl, 0.9 mM CaCl2, 0.5 mM MgCl2, 1.5 mM
KH2PO4, 2.7 mM KCl, and 5 mM glucose). In some cases, NaCl was substituted with NaI,
NaSCN, NaNO3, or sodium glucuronate; all sodium salts were
obtained from Sigma.
RESULTS
Monocyte Populations Differ in Their Release of IL-1
Freshly isolated human monocytes are heterogeneous with respect to
their size and functional properties (23, 24). Moreover, when
maintained in culture these cells may change their biochemical properties (25, 26), including their ability to respond to extracellular ATP (27, 28, 29). Based on this known heterogeneity, a
comparison of the IL-1 posttranslational processing capacity of
freshly isolated monocytes and monocytes that were aged overnight in
culture was performed. Each population was stimulated for 2 h with
LPS, labeled for 60 min with [35S]methionine, and chased
in the absence or presence of ATP. In the absence of ATP, freshly
isolated monocytes released proteolytically processed radiolabeled
17-kDa IL-1 (Table I); based on recovery of total
radiolabeled IL-1 from these cultures, however, the 17-kDa species
generally accounted for <30% of the newly synthesized cytokine. High
concentrations of LPS are known to favor mature IL-1 release (15),
but even at a concentration of 1 µg/ml only 26% of the total
radiolabeled cytokine was recovered as the extracellular mature species
(experiment 2; Table I). Aged monocytes, on the other hand, did not
release significant mature IL-1 in the presence of LPS (Table I). In
contrast, both monocyte populations responded to ATP and released
proteolytically processed 17-kDa IL-1 ; the nucleotide triphosphate,
however, did not affect both populations equally. Thus, freshly
isolated monocytes consistently released >90% of their IL-1 as the
17-kDa mature species but only 50-60% of the radiolabeled cytokine
was released as the mature species from aged monocytes (Table I).
Table I.
Comparison of IL-1 release by fresh and aged human monocytes
Human monocytes were isolated by adherence and treated with LPS
immediately (Fresh) or after overnight culture (Aged). After 2 h
of LPS treatment, cells were labeled with [35S]methionine for
60 min and then chased in the absence or presence of ATP; once added,
LPS remained in all subsequent solutions. The amount of IL-1
recovered as the 17-kDa species (expressed as a % of the total
radiolabeled IL-1 recovered) and the total radioactivity
immunoprecipitated as IL-1 (sum of 17-, 28-, and 31-kDa species
recovered intracellularly and extracellularly and corrected for the
2-fold loss of [35S]methionine that occurred due to formation
of the 17-kDa species) are indicated. Each value is the average of
duplicate determinations. Fresh monocytes were treated with ATP at an
extracellular pH of 7.3, whereas aged monocytes were treated with ATP
in medium at pH 6.9; this pH difference affords maximal
proteolytic processing (16). Fresh monocytes were chased for either 30 min (experiment 1) or for 3 h (experiment 2) and aged cells for
3 h; the LPS concentration in experiments 1, 3, and 4 was 10 ng/ml
and was increased to 1 µg/ml in experiment 2.
| Experiment |
Monocyte population |
Treatment |
Total
IL-1 /LDH |
% of total as 17 kDa IL-1
|
|
| 1 |
Fresh |
No
ATP |
3,970 |
15 |
|
|
+ 2 mM ATP |
17,700 |
92
|
|
| 2 |
Fresh |
No ATP |
81,300 |
26 |
|
|
+ 5 mM ATP |
296,000 |
89 |
|
| 3 |
Aged |
No
ATP |
11,400 |
1 |
|
|
+ 2 mM ATP |
32,200 |
63
|
|
| 4 |
Aged |
No ATP |
5,400 |
1 |
|
|
+ 2 mM ATP |
10,050 |
55 |
|
In the presence of ATP an apparent over-recovery of radiolabeled
IL-1 consistently was observed. For example, a total of 3970 counts
were recovered as IL-1 from LPS-treated fresh monocytes in the
absence of ATP (experiment 1; Table I). Following ATP treatment,
however, total radioactivity recovered as immunoprecipitable IL-1
from an identical culture increased >4-fold (Table I). Since
radiolabeled methionine was removed from the culture medium prior to
the addition of ATP, new synthesis of IL-1 cannot account for this
over-recovery. Moreover, the antibody employed to capture radiolabeled
IL-1 was not limiting. Treatment of monocyte extracts (derived from
cells not exposed to ATP) with increasing polyclonal antibody did not
yield additional radiolabeled IL-1 . Rather, it appeared that
conditions which led to an increase in IL-1 posttranslational
maturation also led to an increase in cytokine recovery. This
over-recovery may result from a decrease in the intracellular turnover
of newly synthesized cytokine and/or a change in IL-1 that allows
recognition by the antibody. Similar differences were observed in the
quantity of radiolabeled IL-1 recovered in the absence or presence
of ATP from aged monocyte cultures (Table I). Although the cause of
this over-recovery remains to be determined, the results indicate that
ATP is a potent inducer of IL-1 release and maturation and that the
extent of these posttranslational processing reactions varies between
different monocyte populations. These differences suggest that the ATP
response is not passive but, rather, requires active participation of
the IL-1 producing cell.
Hypotonic Stress Promotes Release of Mature IL-1 from
LPS-activated Human Monocytes
Based on previous observations suggesting that anion and potassium
fluxes are necessary for the posttranslational maturation of IL-1
(14, 16, 20, 21), LPS-stimulated monocytes were subjected to hypotonic
stress, a treatment known to promote KCl export in a wide variety of
cells (30). Freshly isolated human monocytes were stimulated with LPS
for 2 h, labeled with [35S]methionine for 60 min,
and then chased for 3 h in media of differing ionic strength. The
base medium in this experiment consisted of a standard Dulbecco's
formulation (Table II). Hypotonic media were prepared by
varying the concentrations of NaCl, KCl, and KH2PO4; concentrations of other media
components, including Ca2+, Mg2+,
NaHCO3, glucose, and Hepes, were maintained at constant
values (Table II). The chase media varied in NaCl concentration from 132 to 27 mM.
Table II.
Composition of hypotonic modified Dulbecco's media used to induce
IL-1 release
pH of all solutions was adjusted to 7.3 with NaOH. Values indicate
concentration (mM).
| Component |
Formulation
|
| A |
B |
C |
D |
E
|
|
| NaCl |
132 |
110 |
82 |
55 |
27
|
| KCl |
2.6 |
2.2 |
1.6 |
1.1 |
0.54
|
| KH2PO4 |
1.4 |
1.2 |
0.9 |
0.6 |
0.3
|
| MgCl2 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5
|
| CaCl2 |
0.9 |
0.9 |
0.9 |
0.9 |
0.9 |
| Hepes, pH
7.3 |
20 |
20 |
20 |
20 |
20 |
| NaHCO3, pH
7.3 |
5 |
5 |
5 |
5 |
5
|
| Glucose |
5 |
5 |
5 |
5 |
5 |
|
In normal Dulbecco's medium (Formulation A, Table II), LPS-stimulated
cells released little mature IL-1 and the cell-associated cytokine
persisted as the 35-kDa species (Fig. 1). Addition of 2 mM ATP to this medium, however, promoted complete release
of the radiolabeled cytokine, and externalized IL-1 was processed efficiently to the 17-kDa species (Fig. 1). Importantly, as the concentration of NaCl within the chase medium decreased (in the absence
of exogenous ATP), mature 17-kDa IL-1 increased extracellularly. Thus, in medium containing 55 (Formulation D) and 27 (Formulation E)
mM NaCl, 85 and 97%, respectively, of the total
radiolabeled IL-1 was recovered extracellularly as the 17-kDa
species (Fig. 1).
Fig. 1.
Hypotonic stress promotes IL-1
posttranslational processing. LPS-activated
[35S]methionine-labeled fresh human monocytes were placed
in media that contained the indicated concentration of NaCl; where
indicated, 2 mM ATP also was present. These cultures were
incubated for 3 h after which cells and media were separated, and
IL-1 was recovered from each by immunoprecipitation. The resulting
immunoprecipitates were analyzed by SDS-gel electrophoresis; an
autoradiogram is shown for the cell-associated (A) and media
(B) samples. Each condition was performed in duplicate.
Arrows on the right indicate the migration
position of the 31-kDa pro-IL-1 and 17-kDa mature IL-1
species.
[View Larger Version of this Image (66K GIF file)]
To define the kinetics of this posttranslational processing,
LPS-stimulated [35S]methionine-labeled monocytes were
chased in hypotonic medium for various times. After a 10-min chase,
only a small quantity of radiolabeled IL-1 was recovered in the
medium, and the externalized polypeptides were not proteolytically
processed (Fig. 2). Extracellular 17-kDa IL-1 ,
however, was readily detected after 20 min of hypotonic treatment, and
the quantity of this species increased during longer chase times (Fig.
2). Importantly, beyond the 20 min time point extracellular IL-1 was
recovered almost exclusively as the 17-kDa species (Fig. 2). In
contrast, at all times intracellular cytokine was composed primarily of
the 31-kDa species with only minor amounts of the 17-kDa mature form
being present (data not shown). Externalization of the mature cytokine
species, therefore, occurred more efficiently than release of the
pro-IL-1 polypeptide species. Moreover, only 20% of the cytoplasmic
constituent lactate dehydrogenase (LDH) was displaced to the medium
after 3-h of hypotonic treatment (Fig. 2). Thus, hypotonic stress
promoted formation of 17-kDa IL-1 and selective release of this
species from LPS-activated human monocytes. Hypotonically stressed
monocytes (in medium containing 55 mM NaCl) demonstrated
the same ballooned appearance as previously observed after ATP or
nigericin treatment (data not shown). Although viability was not
assessed, cells demonstrating this dramatically altered appearance are
assumed to be non-vital.
Fig. 2.
Time course of IL-1 posttranslational
processing induced by hypotonic stress. LPS-activated
[35S]methionine-labeled fresh human monocytes were placed
in a hypotonic medium containing 55 mM NaCl (Formulation D,
Table II). After the times indicated, cultures were harvested, and cell
and media fractions were separated. An autoradiogram of the media
IL-1 immunoprecipitates is shown in A; each condition was
performed in duplicate, and migration positions of the 31- and 17-kDa
IL-1 species are indicated. Radioactivity associated with the
various species of IL-1 (both intracellular and extracellular) was
determined; counts recovered as 17-kDa IL-1 , total counts recovered
as IL-1 (sum of 17- and 31-kDa species recovered intracellularly and
extracellularly and corrected for the 2-fold loss of
[35S]methionine that occurred as a result of 17-kDa
formation), and the percentage of the total IL-1 recovered in the
medium as a function of time that the monocytes were maintained within
the hypotonic medium are indicated in B. In addition, the % of the total culture-associated (sum of intracellular and
extracellular) LDH recovered in the medium is indicated. Each point is
the average of duplicate determinations.
[View Larger Version of this Image (52K GIF file)]
The sum of all radioactivity recovered as IL-1 (corrected for the
2-fold loss of 35S-labeled methionines that accompany
formation of the 17-kDa IL-1 species) again indicated that a 4-fold
over-recovery occurred during the 3-h posttranslational maturation
period (Fig. 2). Since quantities of radiolabeled polypeptides are
expected to decrease during the chase as a result of protein turnover,
this over-recovery (relative to the amount recovered from cells in the
absence of a chase) cannot reflect differences in protein degradation.
Rather, the marked increase in immunoprecipitable radioactivity
suggests that pulse-labeled cytokine molecules initially exist within
monocyte detergent extracts as forms that are inaccessible to and/or
not recognized by the antibody and are converted during hypotonic stress to forms that are recognized immunologically.
Medium Composition Affects the ATP and Hypotonic Stress
Responses
To determine whether the ATP-activated IL-1 posttranslational
processing mechanism also involved a volume-sensitive response, monocytes were treated with ATP in a hypertonic medium. Normal RPMI
medium was made hypertonic by the addition of 0.2 M NaCl. LPS-activated [35S]methionine-labeled cells treated with
ATP in this medium did not efficiently process IL-1 to the
17-kDa species nor did they release significant cytokine into their
medium (Fig. 3). In contrast, cells maintained in normal
RPMI demonstrated an efficient ATP response (Fig. 3). ATP-treated
control cultures released 26% of their LDH into the medium, but
monocytes treated with ATP in the hypertonic medium released only 15%
of this cytoplasmic marker.
Fig. 3.
Hypertonic conditions suppress the ATP
response. LPS-activated [35S]methionine-labeled aged
human monocytes were treated with 2 mM ATP for 3 h in
RPMI, pH 6.9, medium or in this same medium made hypertonic with 200 mM NaCl. At the end of this incubation, cells and media
were separated, and IL-1 was recovered by immunoprecipitation. An
autoradiogram of the gel that contained the media immunoprecipitates is
shown in A; each condition was performed in duplicate, and the migration positions of the 31- and 17-kDa IL-1 species are indicated. The quantity of radioactivity associated with the
extracellular 17-kDa species is indicated in B; each
bar is the average of the duplicate determinations.
[View Larger Version of this Image (16K GIF file)]
To explore the role of anions in the ATP-induced response,
LPS-activated [35S]methionine-labeled monocytes were
incubated in isotonic media that contained various sodium salts in
place of NaCl; chaotropic anions (I ,
NO3 , and SCN ) and the
membrane impermeant glucuronate anion were employed. In medium
containing NaCl, monocytes demonstrated an efficient ATP response (Fig.
4); 17-kDa IL-1 was produced and externalized. In
contrast, when monocytes were maintained in a NaI- or NaSCN-based medium, a marked decrease in formation and release of 17-kDa IL-1 was observed (Fig. 4). In the presence of either of these salts, production of 17-kDa IL-1 was reduced by 97% relative to cells maintained in NaCl-containing medium. Likewise, cells maintained in a
NaNO3-based medium demonstrated an impaired response; 56% less 17-kDa IL-1 was produced by cells maintained in
NaNO3 relative to cells maintained in NaCl (Fig. 4). When
the medium contained 137 mM sodium glucuronate, on the
other hand, production of 17-kDa IL-1 was not impaired; rather,
cells maintained in this medium consistently produced slightly greater
amounts of the mature cytokine species (Fig. 4). The percentage of LDH
released by ATP was 25, 10, 9, 16, and 31%, respectively, in media
that contained 137 mM NaCl, NaI, NaSCN, NaNO3,
or sodium glucuronate. Thus, chaotropic anions inhibited ATP-induced
processing and release of IL-1 and the release of LDH.
Fig. 4.
Chaotropic anions inhibit the ATP
response. LPS-stimulated [35S]methionine-labeled
aged monocytes were incubated for 15 min in medium containing 137 mM of the indicated sodium salt, after which they were
treated for 1.5 h with 1 mM ATP. IL-1 was recovered by immunoprecipitation from cell extracts and media samples; an autoradiogram of the gel that contained the media samples is shown in
A. Each condition was performed in duplicate, and the
migration positions of 31- and 17-kDa IL-1 species are indicated.
Radioactivity associated with the 17-kDa IL-1 species was determined
and is indicated in B as a function of the employed salt.
Each bar is the average of duplicate determinations;
numbers within (or above) the bars indicate the
percentage that the radioactivity represents relative to that recovered
from the NaCl-treated control.
[View Larger Version of this Image (36K GIF file)]
To address the possibility that chaotropic anions impaired the
ATP-induced cytokine response by blocking binding of ATP to its cell
surface receptor, monocytes were treated with ATP at different times
relative to the time of substitution of NaI for NaCl within the medium.
When monocytes were placed in NaI either before or at the time of ATP
addition, 17-kDa IL-1 production was blocked efficiently (data not
shown). Likewise, when the medium substitution occurred within 15 min
of ATP addition the cytokine response was inhibited by 87% (Fig.
5). When the NaI for NaCl substitution was delayed
beyond 25 min of ATP addition, however, production of 17-kDa IL-1
was observed (Fig. 5). Thus, NaI blocked the ATP-induced cytokine
response independently of an effect on the initial binding of ATP to
its surface receptor. It should be noted that the anti-IL-1
antiserum immunocaptured radiolabeled IL-1 as efficiently from the
NaI medium as from a NaCl medium; failure to recover 17-kDa IL-1
from the NaI medium, therefore, did not result from impaired
immunoprecipitation.
Fig. 5.
NaI substitution post-ATP addition inhibits
IL-1 processing. LPS-stimulated
[35S]methionine-labeled aged monocytes were placed in a
modified Dulbecco's medium containing 137 mM NaCl, 1%
FBS, and 2 mM ATP. At the times indicated, the medium was
removed from duplicate cultures and replaced with a comparable medium
except that 137 mM NaI was substituted for NaCl. All
cultures were incubated with ATP for a total of 3 h. At the end of
the 3-h treatment, cells and media were separated, and IL-1 was
recovered by immunoprecipitation. Following the initial time of ATP
treatment the NaCl-containing media were clarified by centrifugation
(to remove cells that may have detached) and pooled with the final
media samples prior to the immunoprecipitation step to allow recovery
of any IL-1 that may have been released prior to the NaI medium switch.
The media immunoprecipitates were analyzed by SDS-gel electrophoresis,
and an autoradiogram of the gel is shown in A. The quantity
of radioactivity recovered as extracellular 17-kDa IL- is indicated
in B as a function of the time of the medium
substitution.
[View Larger Version of this Image (35K GIF file)]
Additional evidence that the anion effect on IL-1 processing was not
due to inhibition of ATP binding to its receptor was obtained by asking
if chaotropic anions altered cytokine processing promoted by
hypotonic stress. LPS-activated
[35S]methionine-labeled monocytes were treated
with hypotonic medium that contained 55 mM concentrations
of the individual sodium salts. As expected, cells incubated in
hypotonic NaCl produced and externalized 17-kDa IL-1 (Fig.
6). In contrast, cells maintained in hypotonic NaI
produced only 5% as much 17-kDa IL-1 (Fig. 6). Production of 17-kDa
IL-1 also was reduced in the presence of hypotonic NaSCN, but the
extent of inhibition (<30%) was not equivalent to that obtained in
the NaI-based medium. Monocytes maintained in hypotonic
NaNO3 or sodium glucuronate produced quantities of 17-kDa
IL-1 to that recovered from cells maintained in hypotonic NaCl
(Fig. 6).
Fig. 6.
Effect of chaotropic anions on the hypotonic
stress response. LPS-stimulated
[35S]methionine-labeled fresh monocytes were placed in an
isotonic medium that contained 137 mM of an individual
sodium salt for 15 min, after which these media were replaced with
hypotonic media containing only 55 mM of the same sodium
salt. After a 1.5-h incubation, cells and media were separated, and
IL-1 was recovered from the media samples by immunoprecipitation. An
autoradiogram of the immunoprecipitates (A) and the absolute
amount of radioactivity recovered as extracellular 17-kDa IL-1
(B) are indicated. Each condition was performed in
duplicate, and the bars are the average of the two
determinations; numbers within the bars indicate the percentage relative to the NaCl control.
[View Larger Version of this Image (40K GIF file)]
Pharmacological Effectors
Hypotonic stress promotes a regulated volume decrease (RVD)
response in many cell types that is mediated by a net loss of KCl from
the cytosol (30, 31, 32); the mechanism of KCl loss is cell
type-dependent and may occur by the concerted action of
separate K+ and Cl conducting channels or by
an electroneutral KCl cotransporter (30, 31, 32). In an attempt to link
IL-1 posttranslational processing events to a specific KCl release
mechanism, known effectors of the RVD response were profiled in the
human monocyte cytokine release assay.
Okadaic Acid Inhibits ATP-induced IL-1 Posttranslational
Processing
The protein phosphatase inhibitor okadaic acid impairs
swelling activated KCl cotransport in rabbit red blood cells (33). To
determine whether okadaic acid affected IL-1 posttranslational processing, LPS-activated [35S]methionine-labeled cells
were preincubated with various concentrations of okadaic acid for 20 min and then treated with ATP. Okadaic acid produced a
dose-dependent inhibition in the formation of 17-kDa
IL-1 (Fig. 7); the IC50 for this agent
was 150 nM.
Fig. 7.
Okadaic acid inhibits the ATP response.
LPS-stimulated [35S]methionine-labeled aged monocytes
were placed in RPMI, pH 6.9, medium that contained the indicated
concentration of okadaic acid. After a 20-min incubation, 1 mM ATP was introduced, and the cells were incubated for an
additional 3 h. Cells and media were harvested, and IL-1 was
recovered from each by immunoprecipitation. Media immunoprecipitates
were analyzed by SDS-gel electrophoresis and autoradiography
(A); the region of the autoradiogram that contained 31- and
17-kDa IL-1 is indicated as a function of the okadaic acid
concentration. Each condition was performed in duplicate. The amount of
radioactivity associated with the extracellular 17-kDa species is
indicated in B; each bar is the average of the duplicate determinations. Numbers within the bars indicate
the percentage relative to the control (O nM okadaic
acid).
[View Larger Version of this Image (62K GIF file)]
Quinine Blocks Cytokine Posttranslational Processing
Quinine
sensitivity is a criterion that often is employed to distinguish
between the functioning of separate conductive channels or
cotransporters in the RVD response (34, 35). This agent is reported to
block hypotonic stress-induced K+ channels, and quinine
inhibition is reversed when gramicidin, a potassium conductive
ionophore, is added to the system to provide an alternate
K+ efflux mechanism (35). We previously reported that
potassium selective ionophores such as nigericin and lasalocid can on
their own promote maturation and release of IL-1 from monocytes and macrophages (20). Likewise, gramicidin promoted mature IL-1 release
from LPS-activated human monocytes (Fig. 8). At a
concentration of 2 µM, monocytes treated with this
channel forming ionophore (36) efficiently externalized their newly
synthesized IL-1 in the form of the 17-kDa species (Fig. 8). At a
concentration of 1 mM, comparable with concentrations
reported to inhibit RVD (34), quinine partially blocked both the
gramicidin (39%) and ATP (58%) responses (Fig. 8). Quinine-treated
monocytes did not release additional procytokine nor did they
accumulate processed IL-1 intracellularly (data not shown).
Quinine's ability to impair both the ATP and gramicidin responses
suggests that it is acting independently of a specific K+
channel. Monocytes activated by hypotonic stress also were treated with
quinine; within the hypotonic medium, however, 1 mM quinine promoted release of LDH and 31-kDa pro-IL-1 suggesting that it was
lytic under these conditions (data not shown).
Fig. 8.
Gramicidin promotes IL-1 posttranslational
processing. LPS-stimulated [35S]methionine-labeled
aged monocytes (previously cultured in the presence of 5 ng/ml
granulocyte macrophage colony-stimulating factor) were placed in RPMI
medium and treated for 3 h with either 2 mM ATP or 2 µM gramicidin in the presence or absence of 1 mM quinine; cultures treated with quinine were pretreated
with this agent for 15 min prior to the addition of the release
stimulus. Media IL-1 immunoprecipitates were analyzed by SDS-gel
electrophoresis and autoradiography (A); the region of the
autoradiogram that contained 31- and 17-kDa IL-1 is shown. The
amount of radioactivity associated with extracellular 17-kDa IL-1 is
indicated in B; each bar is the average of the
duplicate determinations. Numbers within the bars indicate
the percentage relative to the ATP or gramicidin-treated
controls.
[View Larger Version of this Image (36K GIF file)]
Ca+2-free Media Do Not Affect the ATP Response
An
RVD response mediated by separate conductive K+ and
Cl channels often is inhibited by removal of
Ca2+ from the medium (34). LPS-stimulated
[35S]methionine-labeled human monocytes treated with ATP
in normal medium and in medium containing 10 mM EGTA
yielded identical amounts of 17-kDa IL-1 (data not shown).
Bumetanide and Furosemide Do Not Impair the ATP
Response
Agents that impair anion transport processes effectively
suppress ATP-induced maturation and release of IL-1 ; such agents include the stilbene derivatives DIDS and SITS and the antiinflammatory agent tenidap (16). In addition, we noted previously that ethacrynic acid is a potent inhibitor of the ATP response of human monocytes; the
IC50 against this response is 3 µM (16).
Ethacrynic acid is used as a diuretic, and this effect, in part, is
attributed to inhibition of kidney cotransporters (37). Two other
diuretic agents, bumetanide and furosemide, are reported to be
selective inhibitors of the
Na+/K+/2Cl cotransporter (38). At
100 µM, a concentration sufficient to impair
Na+/K+/2Cl cotransport (39, 40),
neither of these agents inhibited ATP-induced cytokine
posttranslational processing (Table III).
DISCUSSION
Posttranslational maturation of IL-1 promoted by ATP is not
observed with similar concentrations of AMP, UTP, or GTP, and ADP is
less efficient than ATP (20). This selectivity suggests that ligation
of specific purinoreceptors (P2) activates a signaling mechanism leading to the posttranslational processing of IL-1 (41,
42). Further evidence that the monocyte ATP response involves a signal
transduction mechanism is indicated by the differential sensitivity of
various monocyte populations to ATP. Freshly isolated LPS-activated
monocytes were highly sensitive to purinoreceptor stimulation, and
these cells released >80% of their newly synthesized IL-1 as the
17-kDa cytokine species in the presence of extracellular ATP. In
contrast, monocytes aged overnight prior to LPS activation were less
sensitive to ATP and released 50-60% of their IL-1 as processed
17-kDa IL-1 . Loss of responsiveness may result from down-regulation
of P2 receptors and/or a decrease in an important post-receptor component of the signal transduction machinery. Indeed,
expression of functional P2Z receptors on human monocytes previously was observed to be affected by cell culture conditions (27, 28, 29, 43).
Based on the ability of okadaic acid to inhibit the ATP response,
alterations in the phosphorylation state of mechanistic elements of the
signal transduction pathway also may contribute to changes in monocyte
ATP responsiveness. Likewise, monocytes and macrophages are known to
alter their surface channel properties when maintained in culture
(44, 45, 46), and these changes may affect ATP responsiveness. ATP promotes
major changes in the intracellular ionic environment as a result of its
binding to surface purinoreceptor family members (42, 47, 48, 49, 50, 51, 52). The
identity (i.e. P2X, P2Y,
P2U, or P2Z) of the purinoreceptor subtypes
that are present on monocytes and macrophages is not known; murine
macrophage-like cells and human monocytes appear to express more than
one type of P2 receptor subtype (29, 48, 49). Likewise,
mouse microglial cells appear to express at least two purinergic
receptor subtypes, P2Y and P2Z, and ligation of
the latter has been associated with IL-1 release (53). Thus, a
monocyte's ATP responsiveness is likely to be governed not only by the
presence of one or more members of the purinoreceptor family but also
by the array of specific ion transporters that are components of the
signal transduction pathway.
Data presented previously suggested that potassium and anion fluxes
were necessary components of the mechanism by which ATP promoted
IL-1 posttranslational processing (14, 16, 20, 21). A remarkable
feature of the release process induced by ATP is the dramatic
morphological change that accompanies cytokine externalization. In the
continuous presence of this nucleotide triphosphate LPS-stimulated
monocytes and macrophages swell extensively (14, 16, 20). Mammalian
cells possess a remarkable ability to regulate their cytoplasmic volume
(30, 31), and this regulation is easily visualized when cells are
placed within an osmotically altered media. For example,
Ehrlich ascites tumor cells initially swell after suspension in a
hypotonic medium due to an influx of water. This swelling soon
subsides, however, and within minutes a cell's volume normalizes
despite its persistence within the hypotonic medium (30). This RVD
response often occurs as a result of activation of K+ and
Cl channels or K+/Cl
cotransporters within the plasma membrane. These ion transporters facilitate net loss of KCl followed by the passive movement of H20 and a near restoration of the cell's original volume
(30, 31).
LPS-stimulated monocytes subjected to hypotonic stress responded by
activating both the proteolytic maturation of pro-IL-1 and the
release of the mature 17-kDa cytokine. This activation was not
instantaneous, and monocytes suspended in 55 mM
NaCl-containing buffer required >10 min of treatment to initiate the
processing reactions. This time dependence is consistent with the
notion that the hypotonic conditions triggered changes in the
intracellular ionic environment which, in turn, activated the
posttranslational processing reactions. Importantly, the employed
hypotonic conditions did not simply lyse the monocytes. When mouse
peritoneal macrophages are suspended in an extreme hypotonic medium,
for example, they lyse and release their content of both LDH and
IL-1 ; the released cytokine, however, is not processed to the mature
17-kDa species (14). Lysis, therefore, is not sufficient to promote
correct posttranslational processing. In contrast, after 30 min of
moderate hypotonic exposure, virtually all of the recovered IL-1
released by human monocytes was processed to the 17-kDa mature species. Cell-associated cytokine, on the other hand, remained predominantly as
higher molecular mass species. Moreover, <10% of the total LDH
associated with the monocyte cultures was recovered in the medium after
30 min of hypotonic treatment. This selective externalization of the
17-kDa cytokine species, therefore, suggests that the majority of the
monocytes possessed intact membranes during the initial period of
hypotonic treatment. With prolonged treatment times, however, the
amount of extracellular LDH increased indicating that membrane
integrity was compromised. The ability of hypotonic stress to promote
IL-1 posttranslational processing also has been reported by an
independent group (21).
As with ATP-treated cells, monocytes subjected to hypotonic stress
developed a swollen appearance that correlated temporally with the
release of mature IL-1 . Therefore, if hypotonic stress activated an
RVD-like response in monocytes, this response apparently failed as the
volume did not normalize. Swelling induced by ATP treatment of human
monocytes was suppressed when these cells were maintained in the
presence of a hypertonic medium; likewise, the hypertonic medium
blocked ATP-induced posttranslational processing of IL-1 .
Volume-activated changes, therefore, appear to be important elements of
both the ATP- and hypotonic-induced cytokine responses.
Substitution of chaotropic anions for Cl ions in the
medium also impaired the ATP and hypotonic responses. Iodide anions, for example, completely suppressed both responses. The thiocyanate anion was an effective inhibitor of the ATP response but was less effective against the hypotonic stress response, and nitrate anions partially suppressed the ATP response without affecting the hypotonic response. In contrast, glucuronate anions did not inhibit the ATP or
hypotonic stress-induced posttranslational processing of IL-1 . The
employed chaotropic anions are, to varying degrees, permeant to
biological membranes, and they are expected to enter the cytosol (54,
55); the glucuronate anion, on the other hand, is membrane-impermeant.
Cotransporters possess a very high selectivity for Cl
ions, and chaotropic anions often inhibit cotransport function (54, 55, 56). Likewise, some Cl channels are inhibited by
I anions (57) although others are less discriminating and
will facilitate transport of divergent anions such as I
and SCN (30, 58). Based on the remarkable inhibition
observed in the presence of the chaotropic anions, therefore, function
of a selective chloride transporter is suggested. If ATP and hypotonic stress were initiating IL-1 posttranslational processing simply by
opening non-selective pores in the membrane, then one would not expect
to observe this strong anion dependence. The degree of inhibition
obtained in the presence of chaotropic anions is likely to reflect
their ability to penetrate the monocyte membrane and access the anion
transporter under the different experimental situations.
Removal of extracellular Ca2+ by addition of the calcium
chelator EGTA did not impair the ATP response; entry of extracellular Ca2+, therefore, is not necessary, and this divalent cation
independence suggests that a Ca2+-activated K+
channel is not operative in the cytokine response. These data, however,
do not eliminate the possibility that release of Ca2+ from
intracellular stores is sufficient for channel activation. Quinine
inhibited ATP-induced posttranslational processing of IL-1 , but this
inhibitory effect also was observed when gramicidin served as the
stimulus. Since gramicidin is expected to facilitate K+
loss independently of a K+ channel, quinine's inhibitory
effect does not appear to result from inhibition of a specific
K+ channel; high concentrations of quinine required to
block cytokine posttranslational processing probably affected multiple
cellular components. Finally, anion transport inhibitors such as DIDS, 5-nitro-2-(3-phenylpropylamino)benzoic acid, and ethacrynic acid suppress ATP-induced IL-1 posttranslational processing (16); these
agents are not selective, and they are reported to impair cotransporters as well as anion channels (59, 60). Two specific blockers of the Na+/K+/2Cl
cotransporter, bumetanide and furosemide, did not inhibit the ATP
response at concentrations that were sufficient to inhibit cotransport
functions.
Taken together, these data suggest a role for a specific anion
transporter in the IL-1 response, but the nature of this transporter (channel versus cotransporter) remains to be determined. A
number of different Cl channels have been cloned (57),
but the monocyte repertoire of such channels is unknown; these cells
are reported to possess a SITS-inhibitable chloride channel (45). A
K+/Cl cotransporter was cloned recently, but
it is not known whether monocytes express this protein (61); moreover,
this cloned cotransporter was inhibited by bumetanide suggesting that
it is not involved in the bumetanide-insensitive monocyte cytokine
response. The apparent diversity in the nature of agents that promote
posttranslational maturation of IL-1 may be explained based on a
shared ability of these agents to activate chloride and potassium
transport. Ionophores such as gramicidin and nigericin are expected to
depolarize monocytes. Likewise, ATP stimulation of murine macrophages
causes depolarization as a result of the opening of a large
non-selective pore in the membrane, and hypotonic stress also may
elicit depolarization (34, 47). Thus, membrane depolarization may serve
as the common trigger that activates cytokine posttranslational
processing. The exact nature of the ionic events that underlie
subsequent steps culminating in cytokine posttranslational processing
remains unclear, but lowering intracellular concentrations of KCl as a result of activation of KCl efflux and/or an increase in cell volume
may facilitate ICE activation and conversion of pro-IL-1 to its
mature counterpart. Catalytic activity of ICE is inhibited by ionic
conditions in excess of 50 mM (62), and within
LPS-activated cells this enzyme is inactive (63). After initiation of
IL-1 posttranslational processing with nigericin, however, active
ICE is observed (64). In addition, ionic signals may regulate IL-1 export (65).
FOOTNOTES
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 860-441-5483;
Fax: 860-441-5719.
1
The abbreviations used are: IL-1 , interleukin
1 ; ICE, interleukin 1 converting enzyme; LDH, lactate dehydrogenase;
LPS, lipopolysaccharide; RVD, regulated volume decrease; DIDS,
4,4 -diisothiocyanatostilbene-2,2 -disulfonic acid; FBS, fetal bovine
serum; SITS, 4-acetamido-4 -isothiocyanatostilbene-2,2 -disulfonic acid.
REFERENCES
-
Dinarello, C. A.
(1991)
Blood
77,
1627-1652
[Medline]
[Abstract/Free Full Text]
-
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., and O'Connor, J. V.
(1986)
J. Exp. Med.
163,
1433-1450
[Medline]
[Abstract/Free Full Text]
-
Bevilacqua, M. P., Stengelin, S., Gimbrone, M. A., Jr., and Seed, B.
(1989)
Science
243,
1160-1164
[Medline]
[Abstract/Free Full Text]
-
Dayer, J.-M., de Rochemonteix, B., Burrus, B., Demczuk, S., and Dinarello, C. A.
(1986)
J. Clin. Invest.
77,
645-648
[Medline]
-
Stephenson, M. L., Goldring, M. B., Birkhead, J. R., Drane, S. M., Rahmsdorf, J. J., and Angel, P.
(1987)
Biochem. Biophys. Res. Commun.
144,
583-590
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Dodge, G. R., and Poole, R.
(1989)
J. Clin. Invest.
83,
647-661
[Medline]
-
Burchett, S. K., Weaver, W. M., Westall, J. A., Larsen, A., Kronheim, S., and Wilson, C. B.
(1988)
J. Immunol.
140,
3473-3481
[Medline]
[Abstract]
-
Wewers, M. D., and Herzyk, D. J.
(1989)
J. Immunol.
143,
1635-1641
[Medline]
[Abstract]
-
Schindler, R., Gelfand, J. A., and Dinarello, C. A.
(1990)
Blood
76,
1631-1638
[Medline]
[Abstract/Free Full Text]
-
Arend, W. P., Gordon, D. F., Wood, W. M., Janson, R. W., Joslin, F. G., and Jameel, S.
(1989)
J. Immunol.
143,
118-126
[Medline]
[Abstract]
-
Herzyk, D. J., Allen, J. N., Marsh, C. B., and Wewers, M. D.
(1992)
J. Immunol.
149,
3052-3058
[Medline]
[Abstract]
-
Landis, R. C., Friedman, M. L., Fisher, R. I., and Ellis, T. M.
(1991)
J. Immunol.
146,
128-135
[Medline]
[Abstract]
-
Hogquist, K. A., Nett, M. A., Unanue, E. R., and Chaplin, D. D.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
8485-8489
[Medline]
[Abstract/Free Full Text]
-
Perregaux, D., Barberia, J., Lanzetti, A. J., Geoghegan, K. F., Carty, T. J., and Gabel, C. A.
(1992)
J. Immunol.
149,
1294-1303
[Medline]
[Abstract]
-
Chin, J., and Kostura, M. J.
(1993)
J. Immunol.
151,
5574-5585
[Medline]
[Abstract]
-
Laliberte, R., Perregaux, D., Svensson, L., Pazoles, C. J., and Gabel, C. A.
(1994)
J. Immunol.
153,
2168-2179
[Medline]
[Abstract]
-
Hogquist, K. A., Unanue, E. R., and Chaplin, D. D.
(1991)
J. Immunol.
147,
2181-2186
[Medline]
[Abstract]
-
Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M., and Horvitz, H. R.
(1993)
Cell
75,
641-652
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Miura, M., Zhu, H., Rotello, R., Hartwieg, E. A., and Yuan, J.
(1993)
Cell
75,
653-660
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Perregaux, D., and Gabel, C. A.
(1994)
J. Biol. Chem.
269,
15195-15203
[Medline]
[Abstract/Free Full Text]
-
Walev, I., Reske, K., Palmer, M., Valeva, A., and Bhakdi, S.
(1995)
EMBO J.
14,
1607-1614
[Medline]
[Medline]
[Order article via Infotrieve]
-
Laemmli, U. K.
(1970)
Nature
227,
680-685
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lewis, C. E., McCarthy, S. P., Lorenzen, J., and McGee, O. D.
(1989)
Immunology
69,
402-408
-
Wang, S.-Y., Mak, K. L., Chen, L. Y., Chou, M. P., and Ho, C. K.
(1992)
Immunology
77,
298-303
[Medline]
[Medline]
[Order article via Infotrieve]
-
Blanchard, D. K., and Djeu, J. Y.
(1991)
J. Leukocyte Biol.
50,
28-34
[Medline]
[Abstract]
-
Tsai, V., Firestein, G. S., Arend, W., and Zvaifler, N. J.
(1992)
Cell. Immunol.
144,
203-216
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hickman, S. E., Khoury, J. E., Greenberg, S., Schieren, I., and Silverstein, S. C.
(1994)
Blood
84,
2452-2456
[Medline]
[Abstract/Free Full Text]
-
Blanchard, D. K., McMillen, S., and Djeu, J. Y.
(1991)
J. Immunol.
147,
2579-2585
[Medline]
[Abstract/Free Full Text]
-
Falzoni, S., Munerati, M., Ferrari, D., Spisani, S., Moretti, S., and Di Virgilio, F.
(1995)
J. Clin. Invest.
95,
1207-1216
[Medline]
-
Hoffmann, E. K., and Simonsen, L. O.
(1989)
Physiol. Rev.
69,
315-382
[Medline]
[Free Full Text]
-
Grinstein, S., Rothstein, B., Sarkadi, B., and Gelfand, E. W.
(1984)
Am. J. Physiol.
246,
C204-C215
[Medline]
-
Lauf, P. K., Bauer, J., Adragna, N. C., Fujise, H., Zade-Oppen, A. M. M., Ryu, K. H., and Delpire, E.
(1992)
Am. J. Physiol.
263,
C917-C932
[Medline]
-
Jennings, M. L., and Schulz, R. K.
(1991)
J. Gen. Physiol.
97,
799-818
[Medline]
[Abstract/Free Full Text]
-
Sarkadi, B., and Parker, J. C.
(1991)
Biochim. Biophys. Acta
1071,
407-427
[Medline]
[Medline]
[Order article via Infotrieve]
-
Gallin, E. K., Mason, T. M., and Moran, A.
(1994)
J. Cell. Physiol.
159,
573-581
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Pressman, B. C.
(1976)
Annu. Rev. Biochem.
45,
501-530
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Palfrey, H. C., and Leung, S.
(1993)
Am. J. Physiol.
264,
C1270-C1277
[Medline]
-
Hass, M.
(1994)
Am. J. Physiol.
267,
C869-C885
-
Gamba, G., Miyanoshita, A., Lombardi, M., Lytton, J., Lee, W.-S., Mediger, M. A., and Herbert, S. C.
(1994)
J. Biol. Chem.
269,
17713-17722
[Medline]
[Abstract/Free Full Text]
-
O'Grady, S. M., Palfrey, H. C., and Field, M.
(1987)
Am. J. Physiol.
253,
C177-C192
-
El-Moatassim, C., Dornand, J., and Mani, J.-C.
(1992)
Biochim. Biophys. Acta
1134,
31-45
[Medline]
[Medline]
[Order article via Infotrieve]
-
Dubyak, G. R., and El-Moatassim, C.
(1993)
J. Physiol. (Lond.)
265,
C577-C606
-
Steinberg, T. H., Newman, A. S., Swanson, J. A., and Silverstein, S. C.
(1987)
J. Biol. Chem.
262,
8884-8888
[Medline]
[Abstract/Free Full Text]
-
Nelson, D. J., Jow, B., and Jow, F.
(1992)
J. Membr. Biol.
125,
207-218
[Medline]
[Medline]
[Order article via Infotrieve]
-
Nelson, D. J., Jow, B., and Jow, F.
(1990)
J. Membr. Biol.
117,
29-44
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
McKinney, L. C., and Gallin, E. K.
(1990)
J. Membr. Biol.
116,
47-56
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sung, S.-S. J., Young, J. D.-E, Origlio, A. M., Heiple, J. M., Kaback, H. R., and Silverstein, S. C.
(1985)
J. Biol. Chem.
260,
13442-13449
[Abstract/Free Full Text]
-
Greenberg, S., Di Virgilio, F., Steinberg, T. H., and Silverstein, S. C.
(1988)
J. Biol. Chem.
263,
10337-10343
[Medline]
[Abstract/Free Full Text]
-
Alonso-Torre, S. R., and Trautmann, A.
(1993)
J. Biol. Chem.
268,
18640-18647
[Medline]
[Abstract/Free Full Text]
-
Hara, N., Ichinose, M., Sawada, M., Imai, K., and Maeno, T.
(1990)
FEBS
267,
281-287
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Matsuura, H., and Ehara, T.
(1992)
Circ. Res.
70,
851-855
[Medline]
[Abstract/Free Full Text]
-
Stutts, M. J., Chinet, T. C., Mason, S. J., Fullton, J. M., Clarke, L. L., and Boucher, R. C.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
1621-1625
[Medline]
[Abstract/Free Full Text]
-
Ferrari, D., Villalba, M., Chiozzi, P., Falzoni, S., Ricciardi-Castagnoli, P., and Di Virgilio, F.
(1996)
J. Immunol.
156,
1531-1539
[Medline]
[Abstract]
-
Lauf, P. K.
(1988)
Am. J. Physiol.
255,
C331-C339
[Medline]
-
O'Neill, W. C.
(1987)
Am. J. Physiol.
253,
C883-C888
-
Hegde, R., and Palfrey, C.
(1992)
J. Membr. Biol.
126,
27-37
[Medline]
[Medline]
[Order article via Infotrieve]
-
Fong, P., and Jentsch, T. S.
(1995)
J. Membr. Biol.
144,
189-197
[Medline]
[Medline]
[Order article via Infotrieve]
-
Li, M., McCann, J. D., and Welsh, M. J.
(1990)
Am. J. Physiol.
259,
C295-C301
[Medline]
-
Soler, A., Rota, R., Hannaert, P., Cragoe, E. J., and Garay, R. P.
(1993)
J. Physiol. (Lond.)
465,
387-401
[Medline]
[Abstract/Free Full Text]
-
Cabantchik, Z. I., and Greger, R.
(1992)
Am. J. Physiol.
262,
C803-C827
[Medline]
-
Gillen, C. M., Brill, S., Payne, J. A., and Forbush, B., III
(1996)
J. Biol. Chem.
271,
16237-16244
[JBC][Medline]
[Abstract/Free Full Text]
-
Black, R. A., Kronheim, S. R., and Sleath, P. R.
(1989)
FEBS Lett.
247,
386-390
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ayala, J. M., Yamin, T.-T., Egger, L. A., Chin, J., Kostura, M. J., and Miller, D. K.
(1994)
J. Immunol.
153,
2592-2599
[Medline]
[Abstract]
-
Miller, B. E., Krasney, P. A., Gauvin, D. M., Holbrook, K. B., Koonz, D. J., Abruzzese, R. V., Miller, R. E., Pagani, K. A., Dolle, R. E., Ator, M. A., and Gilman, S. C.
(1995)
J. Immunol.
154,
1331-1338
[Medline]
[Abstract]
-
Siders, W. M., Klimovitz, J. C., and Mizel, S. B.
(1993)
J. Biol. Chem.
268,
22170-22174
[Medline]
[Abstract/Free Full Text]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Shi, S. Aono, W. Lu, A. J. Ouellette, X. Hu, Y. Ji, L. Wang, S. Lenz, F. W. van Ginkel, M. Liles, et al.
A Novel Role for Defensins in Intestinal Homeostasis: Regulation of IL-1beta Secretion
J. Immunol.,
July 15, 2007;
179(2):
1245 - 1253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Franchi, T.-D. Kanneganti, G. R. Dubyak, and G. Nunez
Differential Requirement of P2X7 Receptor and Intracellular K+ for Caspase-1 Activation Induced by Intracellular and Extracellular Bacteria
J. Biol. Chem.,
June 29, 2007;
282(26):
18810 - 18818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Brough and N. J. Rothwell
Caspase-1-dependent processing of pro-interleukin-1beta is cytosolic and precedes cell death
J. Cell Sci.,
March 1, 2007;
120(5):
772 - 781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Kahlenberg, K. C. Lundberg, S. B. Kertesy, Y. Qu, and G. R. Dubyak
Potentiation of Caspase-1 Activation by the P2X7 Receptor Is Dependent on TLR Signals and Requires NF-{kappa}B-Driven Protein Synthesis
J. Immunol.,
December 1, 2005;
175(11):
7611 - 7622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Verhoef, S. B. Kertesy, K. Lundberg, J. M. Kahlenberg, and G. R. Dubyak
Inhibitory Effects of Chloride on the Activation of Caspase-1, IL-1{beta} Secretion, and Cytolysis by the P2X7 Receptor
J. Immunol.,
December 1, 2005;
175(11):
7623 - 7634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Kahlenberg and G. R. Dubyak
Differing caspase-1 activation states in monocyte versus macrophage models of IL-1{beta} processing and release
J. Leukoc. Biol.,
September 1, 2004;
76(3):
676 - 684.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Kahlenberg and G. R. Dubyak
Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release
Am J Physiol Cell Physiol,
May 1, 2004;
286(5):
C1100 - C1108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sluyter, A. N. Shemon, and J. S. Wiley
Glu496 to Ala Polymorphism in the P2X7 Receptor Impairs ATP-Induced IL-1{beta} Release from Human Monocytes
J. Immunol.,
March 15, 2004;
172(6):
3399 - 3405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Makino, H. Nakamura, E. Ikeda, K. Ohnuma, K. Yamauchi, Y. Yabe, L. Poellinger, Y. Okada, C. Morimoto, and H. Tanaka
Hypoxia-Inducible Factor Regulates Survival of Antigen Receptor-Driven T Cells
J. Immunol.,
December 15, 2003;
171(12):
6534 - 6540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Laliberte, D. G. Perregaux, L. R. Hoth, P. J. Rosner, C. K. Jordan, K. M. Peese, James. F. Eggler, M. A. Dombroski, K. F. Geoghegan, and C. A. Gabel
Glutathione S-Transferase Omega 1-1 Is a Target of Cytokine Release Inhibitory Drugs and May Be Responsible for Their Effect on Interleukin-1beta Posttranslational Processing
J. Biol. Chem.,
May 2, 2003;
278(19):
16567 - 16578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Brough, R. A. Le Feuvre, R. D. Wheeler, N. Solovyova, S. Hilfiker, N. J. Rothwell, and A. Verkhratsky
Ca2+ Stores and Ca2+ Entry Differentially Contribute to the Release of IL-1{beta} and IL-1{alpha} from Murine Macrophages
J. Immunol.,
March 15, 2003;
170(6):
3029 - 3036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Hathaway, G. E. Griffin, P. J. Sansonetti, and J. D. Edgeworth
Human Monocytes Kill Shigella flexneri but Then Die by Apoptosis Associated with Suppression of Proinflammatory Cytokine Production
Infect. Immun.,
July 1, 2002;
70(7):
3833 - 3842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Perregaux, P. McNiff, R. Laliberte, N. Hawryluk, H. Peurano, E. Stam, J. Eggler, R. Griffiths, M. A. Dombroski, and C. A. Gabel
Identification and Characterization of a Novel Class of Interleukin-1 Post-Translational Processing Inhibitors
J. Pharmacol. Exp. Ther.,
October 1, 2001;
299(1):
187 - 197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gudipaty, B. D. Humphreys, G. Buell, and G. R. Dubyak
Regulation of P2X7 nucleotide receptor function in human monocytes by extracellular ions and receptor density
Am J Physiol Cell Physiol,
April 1, 2001;
280(4):
C943 - C953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Perregaux, P. McNiff, R. Laliberte, M. Conklyn, and C. A. Gabel
ATP Acts as an Agonist to Promote Stimulus-Induced Secretion of IL-1{beta} and IL-18 in Human Blood
J. Immunol.,
October 15, 2000;
165(8):
4615 - 4623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. C. Chroneos, S. E. Wert, J. L. Livingston, D. J. Hassett, and J. A. Whitsett
Role of Cystic Fibrosis Transmembrane Conductance Regulator in Pulmonary Clearance of Pseudomonas aeruginosa In Vivo
J. Immunol.,
October 1, 2000;
165(7):
3941 - 3950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Laliberte, J. Eggler, and C. A. Gabel
ATP Treatment of Human Monocytes Promotes Caspase-1 Maturation and Externalization
J. Biol. Chem.,
December 24, 1999;
274(52):
36944 - 36951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mutini, S. Falzoni, D. Ferrari, P. Chiozzi, A. Morelli, O. R. Baricordi, G. Collo, P. Ricciardi-Castagnoli, and F. Di Virgilio
Mouse Dendritic Cells Express the P2X7 Purinergic Receptor: Characterization and Possible Participation in Antigen Presentation
J. Immunol.,
August 15, 1999;
163(4):
1958 - 1965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Perregaux and C. A. Gabel
Human monocyte stimulus-coupled IL-1beta posttranslational processing: modulation via monovalent cations
Am J Physiol Cell Physiol,
December 1, 1998;
275(6):
C1538 - C1547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. S. Edwards, L. M. Sutherland, J. H. T. Power, T. E. Nicholas, and A. W. Murray
Osmotic stress induces both secretion and apoptosis in rat alveolar type II cells
Am J Physiol Lung Cell Mol Physiol,
October 1, 1998;
275(4):
L670 - L678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Esser, W. Glienke, R. Andreesen, R. E. Unger, M. Kreutz, H. Rubsamen-Waigmann, and H. von Briesen
Individual Cell Analysis of the Cytokine Repertoire in Human Immunodeficiency Virus-1-Infected Monocytes/Macrophages by a Combination of Immunocytochemistry and In Situ Hybridization
Blood,
June 15, 1998;
91(12):
4752 - 4760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Perregaux and C. A. Gabel
Post-Translational Processing of Murine IL-1: Evidence that ATP-Induced Release of IL-1{alpha} and IL-1{beta} Occurs via a Similar Mechanism
J. Immunol.,
March 1, 1998;
160(5):
2469 - 2477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Marathe, S. L. Schissel, M. J. Yellin, N. Beatini, R. Mintzer, K. J. Williams, and I. Tabas
Human Vascular Endothelial Cells Are a Rich and Regulatable Source of Secretory Sphingomyelinase. IMPLICATIONS FOR EARLY ATHEROGENESIS AND CERAMIDE-MEDIATED CELL SIGNALING
J. Biol. Chem.,
February 13, 1998;
273(7):
4081 - 4088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Hughes Jr., C. D. Bortner, G. D. Purdy, and J. A. Cidlowski
Intracellular K+ Suppresses the Activation of Apoptosis in Lymphocytes
J. Biol. Chem.,
November 28, 1997;
272(48):
30567 - 30576.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|